Search Menu

Articles 2016

Bäckman S, Larjo A, Soikkeli J, Castrén J, Ihalainen J, Syrjälä M. Season and time of day affect capillary blood hemoglobin level and low hemoglobin deferral in blood donors: analysis in a national blood bank. Transfusion 2016;56(6):1287-94. PM: 27018648

Cui LL, Kinnunen T, Boltze J, Nystedt J, Jolkkonen J. Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study. Stem Cells International 2016;2016:1764938. PM: 27022399

Goldman M, Magnussen K, Gorlin J..... Castrén J et al. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang. 2016;111(4):449-55. PM: 27564140

Ihalainen J. Ajankohtaisesti preanalytiikasta. Moodi 2016;39(1):1.

Ihalainen J, Lauronen J, Syrjälä M. Verivalmisteiden kulutuksen muutokset Suomessa 2007–2014. Duodecim 2016;132(11)1017-24

Ihalainen J. Nykyisyys rakentaa tulevat muistot. Moodi 2016;39(6):5.

Ihalainen J. Suuressa verikeskuksessa hätätilanteet ovat rutiinia. Moodi 2016;39(6):17-18.

Impola U, Larjo A, Salmenniemi U, Putkonen M, Itälä-Remes M, Partanen J. Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML. Frontiers in Immunology 2016;7:Article 523.

Jernman R, Haimila K, Korhonen A, Sareneva I, Sulin K, Uotila J, Kuosmanen M, Sainio S. Anti-Ula as the Cause of Severe Hemolytic Disease of the Fetus and Newborn: A Case Report. Gynecology & Obstetrics Case Report. 2016;2(2):23.

Kaartinen T, Harjunpää H, Partanen J, Tiittanen M. In vitro Treg expansion favors the full-length splicing isoform of CTLA4. Immunotherapy 2016 May;8(5):541-53. PM: 27140408

Kaartokallio T, Lokki AI, Peterson H, Kivinen K, Hiltunen L, Salmela E, Lappalainen T, Maanselkä P, Heino S, Knuutila S, Sayed A, Poston L, Brennecke SP, Johnson MP, Morgan L, Moses EK, Kere J and Laivuori H. Preeclampsia does not share common risk alleles in 9p21 with coronary artery disease and type 2 diabetes. Annals of Medicine 2016;48(5):330-6. PM: 27111527

Kerkelä E, Laitinen A, Räbinä J, Valkonen S, Takatalo M, Larjo A, Veijola J, Lampinen M, Siljander P, Lehenkari P, Alfthan K, Laitinen S. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells. Stem Cells 2016;34(3):781-90. PM: 26731338

Kilpinen L, Parmar A, Greco D, Korhonen M, Lehenkari P, Saavalainen P and Laitinen S. Expansion induced microRNA changes in bone marrow mesenchymal stromal cells reveals interplay between immune regulation and cell cycle. Aging (Albany NY). 2016;8(11):2799-813. PM: 27852979

Kiminkinen LK, Krusius T, Javela KM. Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium. Vox Sanguinis 2016;111(2):120-6. PM: 27060862

Kivelä JM, Kosola S, Peräsaari J, Mäkisalo H, Jalanko H, Holmberg C, Pakarinen MP, Lauronen J. Donor Specific Antibodies after pediatric liver transplantation: A cross-sectional study of 50 patients. Transplant International 2016;29(4):494-505. PM: 26806435.

Klemetti R, Gissler M, Sainio S, Hemminki E. At what age does the risk for adverse maternal and infant outcomes increase - nationwide register-based study on first births in Finland in 2005-2014? Acta Obstetricia et Gynecologica Scandinavica 2016;95(12):1368-75. PM: 27623182

Koljonen V, Tuimala J, Haglund C, Tukiainen E, Vuola J, Juvonen E, Lauronen J, Krusius T. The Use of Blood Products in Adult Patients with Burns. Scandinavian Journal of Surgery 2016;105(3):178-85. PM: 26929291

Laitinen A, Lampinen M, Liedtke S, Kilpinen L, Kerkelä E, Sarkanen J-R, Heinonen T, Kogler G, Laitinen S. The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood. Cytotherapy 2016;18(3):423-437. PM: 26857232

Laitinen A, Oja S, Kilpinen L, Kaartinen T, Möller J, Laitinen S, Korhonen M, Nystedt J. A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells. Cytotechnology 2016;68(4):891-906. PM: 25777046

Lampinen M, Vento A, Laurikka J, Nystedt J, Mervaala E, Harjula A, Kankuri E. Rational autologous cell sources for therapy of heart failure -vehicles and targets for gene and RNA therapies. Current Gene Therapy 2016;16(1):21-33. PM: 26725880

Linjama T, Impola U, Niittyvuopio R, Kuittinen O, Kaare A, Rimpiläinen J, Volin L, Peräsaari J, Jaatinen T, Lauronen J, Saarinen T, Juvonen E, Partanen J, Koskela S. Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region. HLA 2016;87(5):350-355. PM: 26969202

Nance S, Scharberg EA, Thornton N, Yahalom V, Sareneva I, Lomas-Francis C. International rare donor panels: a review. Vox Sanguinis 2016;110(3):209-218. PM: 26689301

Peräsaari JP, Kyllönen LE, Salmela KT, Merenmies JM. Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation. Nephrology Dialysis Transplantation 2016;31(4):672-8. PM: 26614272 

Sareneva IM, Ekblom-Kullberg S. Finnish national rare donor program. Immunohematology. 2016;32(1):21. PM: 27858418

Skog MS, Nystedt J, Korhonen M, Anderson H, Lehti TA, Pajunen MI, et al. Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells. Stem Cell Research and Therapy 2016;7(1):113,016-0373-5. PM: 27528376

Sober S, Rull K, Reiman M, Ilisson P, Mattila P and Laan M. RNA sequencing of chorionic villi from recurrent pregnancy loss patients reveals impaired function of basic nuclear and cellular machinery. Scientific Reports 2016;6:38439. PM: 27929073

Sonneveld ME, Natunen S, Sainio S, Koeleman CA, Holst S, Dekkers G, Koelewijn J, Partanen J, van der Schoot CE, Wuhrer M, Vidarsson G. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. British Journal of  Haematology 2016;174(2):310-20. PM: 27017954

Sorensen BS, Szer J, Shaw B, Korhonen M, Mengling T, Fechter M, Elmoazzen H, Lindberg B, Chapman J, Norgaard JM, Foeken L, Hwang WY, Nielsen B. Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned. Bone Marrow Transplantation 2016 Jul;51(7):1016-8. PM: 26974269

Suutari T, Silen T, S En Karaman D, Saari H, Desai D, Kerkelä E, Laitinen S, Hanzlikova M, Rosenholm JM, Yliperttula M and Viitala T. Real-Time Label-Free Monitoring of Nanoparticle Cell Uptake. Small. 2016;12(45):6289-300. PM: 27690329

Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J. Safety of Living Donation of Hematopoietic Stem Cells. Transplantation 2016;100(6):1329-3. PM: 27136264

Syrjälä M, Ebeling F. Trombosyyttivalmisteet - rajallinen luonnonvara. Duodecim 2016;132(11)999-1000.

Walhfors T, Vesterinen T. Hematologinen biopankki hematologisten tautien tutkimuksen tukena. BestPractice Onkologia/Hematologia 2016;5(19):48-51.

Vepsäläinen K, Lassila R, Arola M, Huttunen P, Koskinen S, Ljung R, Lähteenmäki P, Möttönen M, Riikonen P.Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicenter study in Finland. Haemophilia Journal 2016;22(5):721-9. PM: 27339837